
Olopatadine (0.2% w/v)
Active composition
Olopatadine inhibits the release of histamine from mast cells, alleviating allergic symptoms in the eyes.
Medical applications
Oloplus OD Eye Drop contains Olopatadine 0.2% w/v, a selective histamine H1 receptor antagonist with dual action as an antihistamine and mast cell stabilizer, indicated for the treatment of allergic conjunctivitis. This ophthalmic solution effectively alleviates symptoms such as itching, redness, and swelling associated with allergic eye conditions by inhibiting the release of histamine and other inflammatory mediators from mast cells. Olopatadine’s rapid onset of action provides prompt relief, while its prolonged duration allows once-daily dosing, enhancing patient compliance. The formulation is preservative-free or contains minimal preservatives to reduce the risk of ocular irritation and enhance tolerability. Oloplus OD Eye Drop is suitable for adults and children above the age of three years and should be administered as one drop in the affected eye(s) once daily or as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to Olopatadine or any component of the formulation. Contact lens wearers should remove lenses prior to instillation and may reinsert lenses after 15 minutes. Adverse effects are generally mild and transient, including eye irritation or burning sensation. Oloplus OD Eye Drop offers an effective and convenient therapeutic option for managing allergic conjunctivitis symptoms.
Dibenzoxepine Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Oloplus OD Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Oloplus OD Eye Drop is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
No interaction found/established
Exercise Caution
Oloplus OD Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Oloplus OD Eye Drop

Olopatadine (0.2% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Olopatadine inhibits the release of histamine from mast cells, alleviating allergic symptoms in the eyes.
Medical applications
Oloplus OD Eye Drop contains Olopatadine 0.2% w/v, a selective histamine H1 receptor antagonist with dual action as an antihistamine and mast cell stabilizer, indicated for the treatment of allergic conjunctivitis. This ophthalmic solution effectively alleviates symptoms such as itching, redness, and swelling associated with allergic eye conditions by inhibiting the release of histamine and other inflammatory mediators from mast cells. Olopatadine’s rapid onset of action provides prompt relief, while its prolonged duration allows once-daily dosing, enhancing patient compliance. The formulation is preservative-free or contains minimal preservatives to reduce the risk of ocular irritation and enhance tolerability. Oloplus OD Eye Drop is suitable for adults and children above the age of three years and should be administered as one drop in the affected eye(s) once daily or as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to Olopatadine or any component of the formulation. Contact lens wearers should remove lenses prior to instillation and may reinsert lenses after 15 minutes. Adverse effects are generally mild and transient, including eye irritation or burning sensation. Oloplus OD Eye Drop offers an effective and convenient therapeutic option for managing allergic conjunctivitis symptoms.
Dibenzoxepine Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Oloplus OD Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Oloplus OD Eye Drop is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
No interaction found/established
Exercise Caution
Oloplus OD Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Oloplus OD Eye Drop















